GLP-1 AMPLIFIER

Key Benefits

 

• Supports GLP-1 Activity - Berberine, cinnamon bark oil, DIM, milk thistle extract, quercetin, and resveratrol help mimic natural GLP-1 activity to support metabolic function and appetite regulation.
• Promotes Glucose Balance - Berberine and cinnamon help regulate blood sugar and support insulin sensitivity.
• Encourages Satiety - GLP-1 support helps reduce appetite for weight management.
• Supports a Healthy Inflammatory Response - Along with natural GLP-1 activity, the polyphenols resveratrol and quercetin also support a healthy inflammatory response by regulating pro-inflammatory pathways.
• Supports Liver and Gut Health - Milk thistle and DIM aid liver detox pathways and help manage glucose metabolism and uptake.
• Uses Fast-Acting Liposomal Delivery Technology - Quicksilver's signature nanoemulsion technology supports rapid absorption and cellular uptake of ingredients.

 

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.

• Take 1 teaspoon by mouth twice daily and hold for 30-90 seconds before swallowing. 
• Best taken on an empty stomach at least 20 minutes before meals.
• If pregnant, breastfeeding or planning to become pregnant, consult a physician before use.

 

Store at room temperature.

The Quicksilver Advantage

 

GLP-1 Amplifier uses our advanced nanoemulsion delivery system technology to help this blend of bioactive phytocompounds reach your cells quickly. Efficient absorption of ingredients means faster action and targeted support for healthy blood sugar levels, appetite regulation, and metabolic clarity.

Müller TD, Finan B, Bloom SR, et al. Glucagon-like peptide 1 (GLP-1). Mol Metab. 2019;30:72-130. doi:10.1016/j.molmet.2019.09.010 https://doi.org/10.1152/physrev.00034.2006

 

Green C, Zaman V, Blumenstock K, Banik NL, Haque A. Dysregulation of Metabolic Peptides in the Gut–Brain Axis Promotes Hyperinsulinemia, Obesity, and Neurodegeneration. Biomedicines. 2025; 13(1):132. https://doi.org/10.3390/biomedicines13010132

 

SNeeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon‐like peptide‐1‐based therapies and mitigation strategies. Diabetes Obes Metab. 2024;26(S4):16-27. https://doi.org/10.1111/dom.15728

 

Xu L, Zhao W, Wang D, Ma X. Chinese medicine in the battle against obesity and metabolic diseases. Front Physiol. 2018;9. https://doi.org/10.3389/fphys.2018.00850

 

Yang WL, Zhang CY, Ji WY, et al. Berberine metabolites stimulate GLP-1 secretion by alleviating oxidative stress and mitochondrial dysfunction. Am J Chin Med. Published online February 8, 2024:1-22.https://doi.org/10.1142/s0192415x24500113

 

Ye Y, Liu X, Wu N, et al. Efficacy and safety of berberine alone for several metabolic disorders: A systematic review and meta-analysis of randomized clinical trials. Front Pharmacol. 2021;12. https://doi.org/10.3389/fphar.2021.653887

 

Zhang Q, Xiao X, Li M, et al. Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine. BMC Complement Alternat Med. 2014;14(1). https://doi.org/10.1186/1472-6882-14-188

 

Yu Y, Hao G, Zhang Q, et al. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways. Biochem Pharmacol. 2015;97(2):173-177. https://doi.org/10.1016/j.bcp.2015.07.012

 

Namazi N, Khodamoradi K, Khamechi SP, Heshmati J, Ayati MH, Larijani B. The impact of cinnamon on anthropometric indices and glycemic status in patients with type 2 diabetes: A systematic review and meta-analysis of clinical trials. Complement Ther Med. 2019;43:92-101. https://doi.org/10.1016/j.ctim.2019.01.002

 

Xiao F, Gao F, Zhou S, Wang L. The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction: A meta-analysis. Medicine. 2020;99(40):e22249. https://doi.org/10.1097/MD.0000000000022249

 

Dhanya R. Quercetin for managing type 2 diabetes and its complications, an insight into multitarget therapy. Biomed Pharmacother. 2022;146:112560. https://doi.org/10.1016/j.biopha.2021.112560

 

Hira T, Trakooncharoenvit A, Taguchi H, Hara H. Improvement of Glucose Tolerance by Food Factors Having Glucagon-Like Peptide-1 Releasing Activity. Int J Mol Sci. 2021;22(12):6623. https://doi.org/10.3390/ijms22126623

 

Liu K, Zhou R, Wang B, Mi MT. Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr. 2014;99(6):1510-1519. https://doi.org/10.3945/ajcn.113.082024